Search Results - "Megan E. Coombes"
-
1
Adjuvant therapy for completely resected stage II colon cancer
Published in Cochrane database of systematic reviews (16-07-2008)“…Colon cancer is potentially curable by surgery. Although adjuvant chemotherapy benefits patients with stage III disease, there is uncertainty of such benefit…”
Get more information
Journal Article -
2
Herceptin® (trastuzumab) in HER2-positive early breast cancer: a systematic review and cumulative network meta-analysis
Published in Systematic reviews (14-11-2018)“…Originator trastuzumab (Herceptin®; H) is an antibody-targeted therapy to treat patients with human epidermal growth factor receptor 2-positive (HER2+) early…”
Get full text
Journal Article -
3
A population‐based comparison of treatment patterns, resource utilization, and costs by cancer stage for Ontario patients with triple‐negative breast cancer
Published in Cancer medicine (Malden, MA) (01-10-2020)“…Background There have been few publications exploring the characteristics, treatment pathways, and health‐care costs by stage in patients with a…”
Get full text
Journal Article -
4
Herceptin® (trastuzumab) in HER2-positive early breast cancer: protocol for a systematic review and cumulative network meta-analysis
Published in Systematic reviews (10-10-2017)“…Human epidermal growth factor receptor 2-positive (HER2+) breast cancer is an aggressive disease that makes up about 20% of all invasive breast cancers. HER2+…”
Get full text
Journal Article -
5
Longitudinal adherence to colorectal cancer screening guidelines
Published in The American journal of managed care (01-02-2016)“…To describe adherence with United States Preventive Services Task Force (USPSTF) colorectal cancer (CRC) screening recommendations over a 10-year period in a…”
Get full text
Journal Article -
6
A population-based comparison of treatment patterns, resource utilization, and costs by cancer stage for Ontario patients with hormone receptor-positive/HER2-negative breast cancer
Published in Breast cancer research and treatment (01-01-2021)“…Purpose To update and expand on data related to treatment, resource utilization, and costs by cancer stage in Canadian patients with hormone receptor-positive…”
Get full text
Journal Article -
7
A population-based comparison of treatment, resource utilization, and costs by cancer stage for Ontario patients with HER2-positive breast cancer
Published in Breast cancer research and treatment (01-02-2021)“…Purpose We sought to expand the currently limited, Canadian, population-based data on the characteristics, treatment pathways, and health care costs according…”
Get full text
Journal Article -
8
A qualitative study evaluating causality attribution for serious adverse events during early phase oncology clinical trials
Published in Investigational new drugs (01-10-2011)“…Summary Background In early phase oncology trials, novel targeted therapies are increasingly being tested in combination with traditional agents creating…”
Get full text
Journal Article -
9
Examination for Sexual Assault: Evaluating the Literature for Indicators of Women-Centered Care
Published in Health care for women international (01-01-2009)“…This study aimed to assess the extent to which recent peer-reviewed published literature on the acute management of sexual assault was women-centered. We…”
Get full text
Journal Article -
10
Who's the fairest of them all? Which provincial pharmacare model would best protect Canadians against catastrophic drug costs?
Published in Healthcare quarterly (Toronto, Ont.) (2004)“…Public prescription drug plans vary markedly across Canada. To address perceived inequities in coverage across provinces, the February 2003 First Ministers'…”
Get more information
Journal Article -
11
O-6-D04/1793/Comparison of the HUI-3 and SF-6D in Patients with Latent and Active Tuber-Culosis
Published in Quality of life research (01-11-2005)Get full text
Journal Article